soluble anti-cd28 abs clone 37.51 (Bio X Cell)
Structured Review
![(A) Naïve CD4 + T-cells from CK2α fl/fl or CK2α fl/fl dLck-Cre mice were polarized under Th1 conditions [anti-CD3 (1 μg/ml), <t>anti-CD28</t> (1 μg/ml), IL-12 (10 ng/ml) and anti-IL-4 (10 μg/ml)] for 3 days. IFN-γ production by CD4 + T-cells was detected by intracellular staining. Representative flow cytometry profiles of IFN-γ production by CD4 + T-cells is shown (n = 5). (B) IFN-γ in the supernatant was measured by ELISA (n=3). (C) Naïve CD4 + T-cells from CK2α fl/fl mice or CK2α fl/fl dLck-Cre mice were activated with anti-CD3 (1 μg/ml) and <t>anti-CD28</t> (1 μg/ml) for 24 h, stimulated with IL-12 (10 ng/ml) for the indicated time points, then phosphorylated P-STAT4 Y693 in CD4 + T-cells was detected by immunoblotting. (D) Relative ratio of phosphorylated P-STAT4 Y693 to total STAT4 at the indicated time points is shown (n=3). (E) Naïve CD4 + T-cells from CK2α fl/fl or CK2α fl/fl dLck-Cre mice were activated with anti-CD3 (1 μg/ml) and anti-CD28 (1 μg/ml) for 24 h, and expression levels of IL-12Rβ1 and IL-12Rβ2 detected by flow cytometry. Representative line graphs are shown. (F) Quantitation of MFI of IL-12Rβ1 and IL-12Rβ2 expression is shown. n=3 in each group. Bars represent the mean ± SD. * p<0.05, *** p< 0.001, **** p< 0.0001.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_2987/pmc07382987/pmc07382987__nihms-1549618-f0003.jpg)
Soluble Anti Cd28 Abs Clone 37.51, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/soluble+anti-cd28+clone+37%2E51/pmc07382987-170-62-82?v=Bio+X+Cell
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Protein Kinase 2 (CK2) Controls CD4 + T-cell Effector Function in the Pathogenesis of Colitis"
Article Title: Protein Kinase 2 (CK2) Controls CD4 + T-cell Effector Function in the Pathogenesis of Colitis
Journal: Mucosal immunology
doi: 10.1038/s41385-020-0258-x
Figure Legend Snippet: (A) Naïve CD4 + T-cells from CK2α fl/fl or CK2α fl/fl dLck-Cre mice were polarized under Th1 conditions [anti-CD3 (1 μg/ml), anti-CD28 (1 μg/ml), IL-12 (10 ng/ml) and anti-IL-4 (10 μg/ml)] for 3 days. IFN-γ production by CD4 + T-cells was detected by intracellular staining. Representative flow cytometry profiles of IFN-γ production by CD4 + T-cells is shown (n = 5). (B) IFN-γ in the supernatant was measured by ELISA (n=3). (C) Naïve CD4 + T-cells from CK2α fl/fl mice or CK2α fl/fl dLck-Cre mice were activated with anti-CD3 (1 μg/ml) and anti-CD28 (1 μg/ml) for 24 h, stimulated with IL-12 (10 ng/ml) for the indicated time points, then phosphorylated P-STAT4 Y693 in CD4 + T-cells was detected by immunoblotting. (D) Relative ratio of phosphorylated P-STAT4 Y693 to total STAT4 at the indicated time points is shown (n=3). (E) Naïve CD4 + T-cells from CK2α fl/fl or CK2α fl/fl dLck-Cre mice were activated with anti-CD3 (1 μg/ml) and anti-CD28 (1 μg/ml) for 24 h, and expression levels of IL-12Rβ1 and IL-12Rβ2 detected by flow cytometry. Representative line graphs are shown. (F) Quantitation of MFI of IL-12Rβ1 and IL-12Rβ2 expression is shown. n=3 in each group. Bars represent the mean ± SD. * p<0.05, *** p< 0.001, **** p< 0.0001.
Techniques Used: Staining, Flow Cytometry, Enzyme-linked Immunosorbent Assay, Western Blot, Expressing, Quantitation Assay
Figure Legend Snippet: (A) CFSE labeled naïve CD4 + T-cells were activated with the indicated concentrations of anti-CD3 (0.2 μg/ml, 0.5 μg/ml, 1.0 μg/ml) and 1.0 μg/ml of anti-CD28 Abs for 72 h, and proliferation was assessed by CFSE dilution. Representative line graphs are shown. (B) Proliferation index of CD4 + T-cells is shown (n = 3). (C) 1 x 10 6 CFSE labeled naïve CD4 + T-cells from CK2α fl/fl or CK2α fl/fl dLck-Cre mice were transferred into Rag1 −/− mice by i.v. injection. Mice were sacrificed 5 days later, and proliferation of CD4 + T-cells from the spleen was assessed by CFSE dilution. Representative line graphs are shown. (D) Frequencies of cells undergoing proliferation is shown. Data represent pooled results from three independent experiments. CK2α fl/fl , n=6; CK2α fl/fl dLck-Cre, n=8. Bars represent the mean ± SD. ** p<0.01, *** p<0.001, **** p<0.0001.
Techniques Used: Labeling, Injection
Figure Legend Snippet: RNA sequencing of CK2α fl/fl CD4 + T-cells (WT) and CK2α fl/fl dLck-Cre CD4 + T-cells (KO) from the colon at 6 weeks after colitis induction was performed (three to five mice were combined per experiment, two experiments in each group). (A) Summary of genes differentially regulated by CK2α using the following cutoffs are shown: p < 0.05, fold change >1.5. (B) GSEA plot shows enrichment of RNA sequencing data compared with KEGG pathway dataset. (C) Heat map shows TCR signaling relative gene expression. (D) Selected gene expression was validated in CD4 + T-cells from colitis Rag1 −/− mice by qRT-PCR. CK2α fl/fl , n=5; CK2α fl/fl dLck-Cre, n=4. (E) Naive CD4 + T-cells from CK2α fl/fl and CK2α fl/fl dLck-Cre mice were activated with 0.5 μg/ml of anti-CD3 and 1.0 μg/ml of anti-CD28 Abs for 24 h, and expression of NFAT2 was detected by flow cytometry. Representative line graphs and quantitation are shown. n=3 in each group. (F) Naïve CD4 + T-cells from CK2α fl/fl and CK2α fl/fl dLck-Cre mice were activated and transduced with caNFAT2 or empty control vector. GFP + transduced cells were sorted and stimulated with 0.1 μg/ml of anti-CD3 and 1.0 μg/ml of anti-CD28 Abs for 48 h, and expression of ICOS, CD40L and BATF was detected by flow cytometry. Representative line graphs are shown. (G) Quantitation of relative MFI of ICOS, CD40L and BATF is shown. n=3 in each group. (H) GFP + cells were sorted and stimulated with 0.1 μg/ml of anti-CD3 and 1.0 μg/ml of anti-CD28 Abs for 48 h, and proliferating cells detected by Ki-67 staining. Representative line graphs and quantitation are shown. (I) Quantitation of absolute number of Ki-67 + CD4 + T-cells is shown. n=3 in each group. Bars represent the mean ± SD. * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001.
Techniques Used: RNA Sequencing, Gene Expression, Quantitative RT-PCR, Expressing, Flow Cytometry, Quantitation Assay, Transduction, Control, Plasmid Preparation, Staining

